We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
We have been notified about the shortage of Pegasys (peginterferon alfa 2a) injection 135 micrograms/0.5 mL and 180 micrograms/0.5 mL pre-filled syringes.
This medicine is used to treat chronic hepatitis B (CHB) and chronic hepatitis C (CHC), and is commonly prescribed off-label to treat myeloproliferative neoplasms (MPNs).
It is currently being exclusively supplied to patients through the Pegasys Home Delivery Program.
We have approved the supply of an overseas-registered product to help during the shortage. Patients should contact their doctor to review their individual situation.
Please go to About the shortage of Pegasys (peginterferon alfa-2a) injection for more information.
You can also go to the Medicine Shortage Reports Database- external site (search for ‘Pegasys’) for the most up-to-date information.